Keith King To view or add a comment, sign in More Relevant Posts Headline: Wegovy Proven to Protect the HeartEven Without Significant Weight Loss Introduction: A major new study has confirmed that Wegovy, the GLP-1 medication best known for weight loss, offers direct cardiovascular protectioneven for people who lose little or no weight
He summarized that "the most impactful step available right now is not a genetic test." What matters more, he said, is matching the drug to a patient's eating profile and other health conditions, then watching how they respond in the first three months, an approach already recommended by the American Diabetes Association
Naltrexone/bupropion differs significantly from GLP-1 or GIP/GLP-1 active ingredients
If tirzepatide has stalled your progress and you have significant weight loss remaining, the case is strongpending cardiovascular clearance and full regulatory approval
Consider Dietary Adjustments A low-fat diet is recommended when using orlistat to reduce gastrointestinal side effects
But what does the science really show
